Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-11-18
2008-08-19
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C540S526000, C548S485000, C564S170000, C568S812000
Reexamination Certificate
active
07414078
ABSTRACT:
The present invention is directed to novel themisone derivative compounds that have been modified to prevent the formation of the toxic metabolite, 2-phenyl-acrylamide. Compositions comprising such derivative compounds have activity as anesthetics and as neuroprotective agents.
REFERENCES:
patent: 2005/0228033 (2005-10-01), Brown
patent: 2723464 (1977-12-01), None
CAS Search Printout for Zelenin et al. Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1985, 4, 955-6.
CAS Search Printout for DE2723464A1 is provided.
Zelenin et al. Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya 1986, 9, 2080-5; (CAS Abstract Attached).
Blitz et al. Chem. Lab., Univ. Kiel. Ber. 1908, 41, 1379-93; (CAS Abstract attached).
Page et al. Tetrahedron 1992, 48(35), 7265-74; (CAS Abstract and structures attached).
Anderson Rebecca L
Nolan Jason M
Sparks Rodney L.
University of Virginia Patent Foundation
LandOfFree
Oral general anesthetics and metabolitically resistant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral general anesthetics and metabolitically resistant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral general anesthetics and metabolitically resistant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4018268